Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aeglea BioTherapeutics In...

    NASDAQ: AGLE · Real-Time Price · USD
    12.01
    0.75 (6.66%)
    At close: Nov 27, 2023, 10:00 PM

    Aeglea BioTherapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 89.42M 34.86M 15.14M
    Short-Term Investments
    		 513.66M 20.85M 77.99M
    Long-Term Investments
    		 n/a n/a n/a
    Other Long-Term Assets
    		 10K 2.24M 2.68M
    Receivables
    		 n/a 375K 815K
    Inventory
    		 n/a n/a -815K
    Other Current Assets
    		 5.39M 6.17M 5.76M
    Total Current Assets
    		 608.47M 62.26M 98.89M
    Property-Plant & Equipment
    		 n/a 6.65M 8.36M
    Goodwill & Intangibles
    		 n/a n/a n/a
    Total Long-Term Assets
    		 10K 8.89M 11.04M
    Total Assets
    		 608.48M 71.14M 109.93M
    Account Payables
    		 666K 677K 3.32M
    Deferred Revenue
    		 n/a 517K 2.36M
    Short-Term Debt
    		 n/a 625K 436K
    Other Current Liabilities
    		 53.39M 12.84M 14.03M
    Total Current Liabilities
    		 54.06M 14.66M 20.14M
    Long-Term Debt
    		 n/a 4M 4.61M
    Other Long-Term Liabilities
    		 36.62M n/a 16K
    Total Long-Term Liabilities
    		 36.62M 6.18M 5.84M
    Total Liabilities
    		 90.68M 20.84M 25.98M
    Total Debt
    		 n/a 4.63M 5.04M
    Common Stock
    		 13K 6K 5K
    Retained Earnings
    		 -972.43M -425.62M -341.81M
    Comprehensive Income
    		 180K -48K -20K
    Shareholders Equity
    		 517.8M 50.3M 83.94M
    Total Investments
    		 n/a 20.85M 77.99M

    Add to Watchlist